Michael D. Hooven, Director at AtriCure, Inc. (ATRC), bought 1,215 shares at $6.88 ($8K) on 2012-09-07, disclosed to the SEC on 2012-09-07.
Open-market purchase of $8k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |